Delayed emesis

Moderately emetogenic chemotherapy

Fausto Roila, David Warr, Rebecca A. Clark-Snow, Maurizio Tonato, Richard J. Gralla, Lawrence H. Einhorn, Jorn Herrstedt

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Data on the incidence and efficacy of antiemetic prophylaxis against delayed emesis induced by moderately emetogenic chemotherapy are scanty. An overview of the literature has been done that showed the efficacy of dexamethasone in two of three randomized trials. Its optimal dose and duration of administration has not been defined. Only one of four randomized studies showed a statistically significant efficacy of 5-HT3 antagonists. Finally, only weak evidence has been published on the efficacy of dopamine receptor antagonists.

Original languageEnglish (US)
Pages (from-to)104-108
Number of pages5
JournalSupportive Care in Cancer
Volume13
Issue number2
DOIs
StatePublished - Feb 2005
Externally publishedYes

Fingerprint

Serotonin 5-HT3 Receptor Antagonists
Antiemetics
Dopamine Antagonists
Dexamethasone
Vomiting
Drug Therapy
Incidence

Keywords

  • 5-HT antagonist
  • Delayed emesis
  • Dexamethasone
  • Moderately emetogenic chemotherapy

ASJC Scopus subject areas

  • Oncology
  • Nursing(all)

Cite this

Roila, F., Warr, D., Clark-Snow, R. A., Tonato, M., Gralla, R. J., Einhorn, L. H., & Herrstedt, J. (2005). Delayed emesis: Moderately emetogenic chemotherapy. Supportive Care in Cancer, 13(2), 104-108. https://doi.org/10.1007/s00520-004-0700-8

Delayed emesis : Moderately emetogenic chemotherapy. / Roila, Fausto; Warr, David; Clark-Snow, Rebecca A.; Tonato, Maurizio; Gralla, Richard J.; Einhorn, Lawrence H.; Herrstedt, Jorn.

In: Supportive Care in Cancer, Vol. 13, No. 2, 02.2005, p. 104-108.

Research output: Contribution to journalArticle

Roila, F, Warr, D, Clark-Snow, RA, Tonato, M, Gralla, RJ, Einhorn, LH & Herrstedt, J 2005, 'Delayed emesis: Moderately emetogenic chemotherapy', Supportive Care in Cancer, vol. 13, no. 2, pp. 104-108. https://doi.org/10.1007/s00520-004-0700-8
Roila F, Warr D, Clark-Snow RA, Tonato M, Gralla RJ, Einhorn LH et al. Delayed emesis: Moderately emetogenic chemotherapy. Supportive Care in Cancer. 2005 Feb;13(2):104-108. https://doi.org/10.1007/s00520-004-0700-8
Roila, Fausto ; Warr, David ; Clark-Snow, Rebecca A. ; Tonato, Maurizio ; Gralla, Richard J. ; Einhorn, Lawrence H. ; Herrstedt, Jorn. / Delayed emesis : Moderately emetogenic chemotherapy. In: Supportive Care in Cancer. 2005 ; Vol. 13, No. 2. pp. 104-108.
@article{0e7f9f04b88f4a33ad1944b6a37a9fe1,
title = "Delayed emesis: Moderately emetogenic chemotherapy",
abstract = "Data on the incidence and efficacy of antiemetic prophylaxis against delayed emesis induced by moderately emetogenic chemotherapy are scanty. An overview of the literature has been done that showed the efficacy of dexamethasone in two of three randomized trials. Its optimal dose and duration of administration has not been defined. Only one of four randomized studies showed a statistically significant efficacy of 5-HT3 antagonists. Finally, only weak evidence has been published on the efficacy of dopamine receptor antagonists.",
keywords = "5-HT antagonist, Delayed emesis, Dexamethasone, Moderately emetogenic chemotherapy",
author = "Fausto Roila and David Warr and Clark-Snow, {Rebecca A.} and Maurizio Tonato and Gralla, {Richard J.} and Einhorn, {Lawrence H.} and Jorn Herrstedt",
year = "2005",
month = "2",
doi = "10.1007/s00520-004-0700-8",
language = "English (US)",
volume = "13",
pages = "104--108",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Delayed emesis

T2 - Moderately emetogenic chemotherapy

AU - Roila, Fausto

AU - Warr, David

AU - Clark-Snow, Rebecca A.

AU - Tonato, Maurizio

AU - Gralla, Richard J.

AU - Einhorn, Lawrence H.

AU - Herrstedt, Jorn

PY - 2005/2

Y1 - 2005/2

N2 - Data on the incidence and efficacy of antiemetic prophylaxis against delayed emesis induced by moderately emetogenic chemotherapy are scanty. An overview of the literature has been done that showed the efficacy of dexamethasone in two of three randomized trials. Its optimal dose and duration of administration has not been defined. Only one of four randomized studies showed a statistically significant efficacy of 5-HT3 antagonists. Finally, only weak evidence has been published on the efficacy of dopamine receptor antagonists.

AB - Data on the incidence and efficacy of antiemetic prophylaxis against delayed emesis induced by moderately emetogenic chemotherapy are scanty. An overview of the literature has been done that showed the efficacy of dexamethasone in two of three randomized trials. Its optimal dose and duration of administration has not been defined. Only one of four randomized studies showed a statistically significant efficacy of 5-HT3 antagonists. Finally, only weak evidence has been published on the efficacy of dopamine receptor antagonists.

KW - 5-HT antagonist

KW - Delayed emesis

KW - Dexamethasone

KW - Moderately emetogenic chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=17644396048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17644396048&partnerID=8YFLogxK

U2 - 10.1007/s00520-004-0700-8

DO - 10.1007/s00520-004-0700-8

M3 - Article

VL - 13

SP - 104

EP - 108

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 2

ER -